Estudios
I+D+I
Institución
Internacional
Vida Universitaria
Atlantis Institut des Sciences Fictives
Recherche
Soumettre
Personnaliser
Vos alertes
Vos paniers
Vos recherches
Aide
EN
/
ES
Accueil
>
articulos
> Vascular resection in perihilar cholangiocarcinoma
Statistiques d'utilisation
Graphiques
Vascular resection in perihilar cholangiocarcinoma
Serrablo A.
(Universidad de Zaragoza)
;
Serrablo L.
;
Alikhanov R.
;
Tejedor L.
Resumen:
Among the cholangiocarcinomas, the most common type is perihilar (phCC), accounting for approximately 60% of cases, after which are the distal and then intrahepatic forms. There is no staging system that allows for a comparison of all series and extraction of conclusions that increase the long-term survival rate of this dismal disease. The extension of the resection, which theoretically depends on the type of phCC, is not a closed subject. As surgery is the only known way to achieve a cure, many aggressive approaches have been adopted. Despite extended liver resections and even vascular resections, margins are positive in around one third of patients. In the past two decades, with advances in diagnostic and surgical techniques, surgical outcomes and survival rates have gradually improved, although variability is the rule, with morbidity and mortality rates ranging from 14% to 76% and from 0% to 19%, respectively. Extended hepatectomies and portal vein resection, or even right hepatic artery reconstruction for the left side tumors are frequently needed. Salvage procedures when arterial reconstruction is not feasible, as well as hepatopancreatoduodenectomy, are still under evaluation too. In this article, we discuss the aggressive surgical approach to phCC focused on vascular resection. Disparate results on the surgical treatment of phCC made it impossible to reach clear-cut conclusions. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Idioma:
Inglés
DOI:
10.3390/cancers13215278
Año:
2021
Publicado en:
Cancers
13, 21 (2021), 5278 [12 pp]
ISSN:
2072-6694
Factor impacto JCR:
6.575 (2021)
Categ. JCR:
ONCOLOGY
rank: 60 / 245 = 0.245
(2021)
- Q1
- T1
Factor impacto CITESCORE:
5.8 -
Medicine
(Q1) -
Biochemistry, Genetics and Molecular Biology
(Q2)
Factor impacto SCIMAGO:
1.349 -
Oncology
(Q1) -
Cancer Research
(Q1)
Tipo y forma:
Article (Published version)
Área (Departamento):
Área Cirugía
(
Dpto. Cirugía
)
Exportado de SIDERAL (2023-05-18-15:26:18)
Permalink:
Copy
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
articulos
>
articulos-por-area
>
cirugia
Retour à la recherche
Notice créée le 2022-09-30, modifiée le 2023-05-19
Versión publicada:
PDF
Évaluer ce document:
Rate this document:
1
2
3
4
5
(Pas encore évalué)
Ajouter au panier personnel
Exporter vers
BibTeX
,
MARC
,
MARCXML
,
DC
,
EndNote
,
NLM
,
RefWorks